Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
Price:
8.22
EUR
Market Cap:
€181.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
|
IT |
|
Tsubakimoto Kogyo Co Ltd
TSE:8052
|
JP |
|
R
|
Reitir fasteignafelag hf
ICEX:REITIR
|
IS |
|
Lyra Therapeutics Inc
NASDAQ:LYRA
|
US |
|
V
|
VAA Vista Alegre Atlantis SGPS SA
ELI:VAF
|
PT |
|
Arteris Inc
NASDAQ:AIP
|
US |
|
Civeo Corp
NYSE:CVEO
|
US |
|
D
|
Datalex PLC
ISEQ:DLE
|
IE |
|
P
|
Polyplex Thailand PCL
SET:PTL
|
TH |
|
B
|
Big Technologies PLC
LSE:BIG
|
UK |
|
Rxsight Inc
NASDAQ:RXST
|
US |
|
Telus Corp
TSX:T
|
CA |
Multiples-Based Value
The Multiples-Based Value of one
FF
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 8.22 EUR,
Fine Foods & Pharmaceuticals NTM SpA
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
FF Multiples-Based Value
LOCKED
Multiples Across Competitors
FF Competitors Multiples
Fine Foods & Pharmaceuticals NTM SpA Competitors
Fine Foods & Pharmaceuticals NTM SpA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IT |
|
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
|
181.3m EUR | 0.5 | 9.7 | 5.1 | 7.9 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
932.9B USD | 326.6 | 3 867.7 | 1 108.4 | 2 134.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
180.6B USD | 4.1 | 26.9 | 18.8 | 25.2 | |
| US |
|
Danaher Corp
NYSE:DHR
|
130B USD | 5.3 | 36 | 18.4 | 26.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.2B CHF | 5.3 | 36.1 | 26.9 | 26.9 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
288.3B CNY | 6.5 | 15.4 | 16 | 16 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.7B USD | 4.5 | 24.5 | 18.1 | 21.4 | |
| US |
|
Waters Corp
NYSE:WAT
|
28.8B USD | 9.1 | 44.7 | 28.9 | 36.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
28.2B USD | 1.7 | 20.8 | 11.7 | 17.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.4B USD | 6.3 | 29.2 | 21.7 | 24.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
